the report we voted on introduced further the safety of pharmaceutical products such as for example the up of inspections of manufacturers outside the european union the basis of analysis
The report we voted on today introduced measures to further ensure the safety of pharmaceutical products such as, for example, the stepping up of inspections of manufacturers outside the European Union on the basis of a risk analysis.
The report we voted on introduced further the safety of pharmaceutical products such as, for example, the up of inspections of manufacturers outside the European Union the basis of a analysis.